Skip to content

BioStem Technologies, Inc.

BSEM · XNAS

CIK 1658678fmd_18FV2316A8BN7PCHEN39F9R4MMManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 4 periods

Latest quarter · Q3 FY2026

Millions
Total revenues
8
Gross profit
4
Operating income
(10)
Net income
(11)
Free cash flow
(9)

Daily close · BSEMIEX trades only

Aug 07, 2026 to Nov 11, 2026 · 58 sessions

1.46 USD

12345Aug 07, 2026Sep 29, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials